Zumutor Biologics

About:

Zumutor Biologics is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics.

Top Investors: Accel, Chiratae Ventures, Karnataka Information Technology Venture Capital Fund, Bharat Innovation Fund, Siana Capital Management

Description:

Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment.

Total Funding Amount:

$47.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2015-01-01

Founders:

Kavitha Iyer Rodrigues, Sohang Chatterjee

Number of Employees:

11-50

Last Funding Date:

2021-12-09

IPO Status:

Private

Industries: